NASDAQ:NTRB Nutriband (NTRB) Stock Price, News & Analysis $7.56 -0.91 (-10.74%) (As of 07/26/2024 ET) Add Compare Share Share Today's Range$7.55▼$8.6750-Day Range$4.77▼$9.2552-Week Range$1.53▼$9.60Volume51,641 shsAverage Volume38,889 shsMarket Capitalization$83.46 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrendsStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends Get Nutriband alerts: Email Address Ad Crypto 101 MediaNext opportunity for crypto millionsThe Bitcoin halving is the #1 creator of "crypto millionaires". That's because historically, every halving has led to a massive bull run in the year after it happens. That means we're in the "golden window" right now…Check out the new "Crypto Bull Run Millionaire Blueprint" now! About Nutriband Stock (NASDAQ:NTRB)Nutriband Inc. develops a portfolio of transdermal pharmaceutical products. Its lead product in development is AVERSA fentanyl, an abuse deterrent fentanyl transdermal system that provides clinicians and patients with an extended-release transdermal fentanyl product for use in managing chronic pain requiring around the clock opioid therapy. The company also develops other products, which include AVERSA buprenorphine and AVERSA methylphenidate; exenatide for type 2 diabetes; and follicle stimulating hormone for infertility. It has a license agreement with Rambam Med-Tech Ltd. for the development of the RAMBAM Closed System Transfer Devices; and Kindeva Drug Delivery, L.P. to develop AVERSAL Fentanyl based on its proprietary AVERSAL abuse deterrent transdermal technology. The company was incorporated in 2016 and is headquartered in Orlando, Florida.Read More NTRB Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart NTRB Stock News HeadlinesJuly 24 at 5:48 AM | americanbankingnews.comNutriband (NASDAQ:NTRB) Stock Price Up 3.5%July 20, 2024 | finanznachrichten.deNutriband, Inc.: Join Nutriband's Exclusive Live Investor Webinar and Q&A Session on July 25July 27, 2024 | Colonial Metals (Ad)Collapse of the PetrodollarThe death of the "petrodollar" seems imminent. And the implications could not be worse for Americans. Russia, China and India have decided to abandon the petrodollar.May 26, 2024 | finance.yahoo.comNutriband Inc. (NTRB)May 23, 2024 | theglobeandmail.comNutriband (NASDAQ: NTRB) Schedules Live Investor Webinar, Q&A SessionMay 21, 2024 | finance.yahoo.comJoin Nutriband's Exclusive Live Investor Webinar and Q&A Session on May 30May 16, 2024 | finanznachrichten.deNutriband Inc.: Nutriband Appoints Accomplished Business Leader Sergei Glinka to its Board of DirectorsMay 8, 2024 | theglobeandmail.comNutriband’s (NASDAQ: NTRB) Transdermal Patch with Abuse-Deterrent Tech Funded to Seek FDA ApprovalJuly 27, 2024 | Colonial Metals (Ad)Collapse of the PetrodollarThe death of the "petrodollar" seems imminent. And the implications could not be worse for Americans. Russia, China and India have decided to abandon the petrodollar.April 25, 2024 | finance.yahoo.comIBN Coverage Initiated for Nutriband Inc.April 24, 2024 | finanznachrichten.deNutriband Inc.: Nutriband Closes $8.4M Private Placement for Commercial Development of Aversa Fentanyl Transdermal Patch Through FDA SubmissionApril 24, 2024 | finance.yahoo.comNutriband Closes $8.4M Private Placement for Commercial Development of Aversa(R) Fentanyl Transdermal Patch Through FDA SubmissionApril 21, 2024 | uk.investing.comNutriband closes funding for abuse-deterrent fentanyl patchApril 1, 2024 | finance.yahoo.comNutriband Inc. Begins Manufacturing for Major Sports Brand Licensee Fit for Life Group, Whose Collection of Partnered Brands Include Reebok, Adidas and New BalanceMarch 28, 2024 | marketwatch.comNutriband Shares Rise 30% After Fentanyl Patch Partnership News, Planned FDA SubmissionMarch 27, 2024 | benzinga.comGerald Goodman's Net WorthMarch 27, 2024 | finanznachrichten.deNutriband Inc.: Nutriband Provides Clinical and Regulatory Path Overview for Lead Product - AVERSA Fentanyl Transdermal PatchMarch 27, 2024 | finance.yahoo.comNutriband Provides Clinical and Regulatory Path Overview for Lead Product - AVERSA(R) Fentanyl Transdermal PatchSee More Headlines Receive NTRB Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Nutriband and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings5/31/2024Today7/27/2024Next Earnings (Estimated)9/09/2024Fiscal Year End1/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Surgical appliances & supplies Sub-IndustryN/A Current SymbolNASDAQ:NTRB CUSIPN/A CIK1676047 Webnutriband.com Phone(407) 377-6695FaxN/AEmployees3Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($0.77) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-5,490,000.00 Net Margins-315.56% Pretax Margin-315.56% Return on Equity-71.77% Return on Assets-56.63% Debt Debt-to-Equity Ratio0.03 Current Ratio6.16 Quick Ratio6.04 Sales & Book Value Annual Sales$2.09 million Price / Sales39.93 Cash FlowN/A Price / Cash FlowN/A Book Value$0.73 per share Price / Book10.36Miscellaneous Outstanding Shares11,040,000Free Float6,274,000Market Cap$83.46 million OptionableNot Optionable Beta1.12 7 Energy Stocks to Buy and Hold ForeverDo you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.Get This Free Report Key ExecutivesMr. Serguei Melnik (Age 50)Founder, President, Company Secretary & Executive Chairman of the Board Comp: $175kMr. Gareth Sheridan (Age 34)Founder, CEO & Director Comp: $175kMr. Gerald Goodman (Age 76)CFO & Chief Accounting Officer Comp: $140kDr. Alan Smith Ph.D. (Age 58)COO & President of 4P Therapeutics Comp: $159kDr. Jeffrey Patrick Pharm.D. (Age 54)Chief Scientific Officer Mr. Michael Myer (Age 39)President of Pocono Pharmaceutical Comp: $40.6kMr. Tyler Overk (Age 40)Head of Active Intelligence More ExecutivesKey CompetitorsEyenoviaNASDAQ:EYENReWalk RoboticsNASDAQ:RWLKLipocineNASDAQ:LPCNConformisNASDAQ:CFMSscPharmaceuticalsNASDAQ:SCPHView All CompetitorsInstitutional OwnershipVirtu Financial LLCBought 12,862 shares on 5/20/2024Ownership: 0.117%View All Institutional Transactions NTRB Stock Analysis - Frequently Asked Questions How have NTRB shares performed this year? Nutriband's stock was trading at $2.32 at the beginning of the year. Since then, NTRB shares have increased by 225.9% and is now trading at $7.56. View the best growth stocks for 2024 here. How were Nutriband's earnings last quarter? Nutriband Inc. (NASDAQ:NTRB) issued its earnings results on Friday, May, 31st. The company reported ($0.21) earnings per share (EPS) for the quarter. The company had revenue of $0.41 million for the quarter. Nutriband had a negative trailing twelve-month return on equity of 71.77% and a negative net margin of 315.56%. When did Nutriband's stock split? Shares of Nutriband split on the morning of Monday, August 15th 2022. The 13-6 split was announced on Monday, August 15th 2022. The newly issued shares were payable to shareholders after the market closes on Monday, August 15th 2022. An investor that had 100 shares of stock prior to the split would have 217 shares after the split. How do I buy shares of Nutriband? Shares of NTRB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:NTRB) was last updated on 7/27/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredGet out of cash before the Fed's next meeting"How I 6X-ed my wife's 401K in 1 year" At the peak of the dot-com boom, a former hedge fund manager put all...Stansberry Research | SponsoredNext opportunity for crypto millionsThe Bitcoin halving is the #1 creator of "crypto millionaires". That's because historically, every halving has...Crypto 101 Media | SponsoredThis student turned $1,300 into $45,000 in just 4 Months!With the help of S.A.M. (my new AI-powered scanner) it's now easier than ever to find these unique trades... ...Monument Traders Alliance | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredThe asset beating inflation by 4xCentral Bank Gold Heist In Progress Central banks are buying gold at record rates... and billionaire invest...Colonial Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nutriband Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Nutriband With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.